Yunnan Botanee Bio-Technology Group Co Ltd is a health industry group integrating research and development, production, and marketing, and is positioned as a skin health Internet. Betteni is committed to creating a skin health ecology in China and promoting the development of China's skincare industry.
2010
n/a
LTM Revenue $897M
LTM EBITDA $126M
$2.1B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Botanee Group has a last 12-month revenue of $897M and a last 12-month EBITDA of $126M.
In the most recent fiscal year, Botanee Group achieved revenue of $758M and an EBITDA of $139M.
Botanee Group expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Botanee Group valuation multiples based on analyst estimatesFY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $688M | $758M | $880M | $897M | XXX |
Gross Profit | $420M | $518M | $560M | XXX | XXX |
Gross Margin | 61% | 68% | 64% | XXX | XXX |
EBITDA | $180M | $139M | $121M | $126M | XXX |
EBITDA Margin | 26% | 18% | 14% | 14% | XXX |
Net Profit | $118M | $144M | $104M | XXX | XXX |
Net Margin | 17% | 19% | 12% | XXX | XXX |
Net Debt | n/a | n/a | n/a | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 21, 2025, Botanee Group's stock price is CNY 42 (or $6).
Botanee Group has current market cap of CNY 17.9B (or $2.5B), and EV of CNY 15.5B (or $2.1B).
See Botanee Group trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$2.1B | $2.5B | XXX | XXX | XXX | XXX | $0.23 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 21, 2025, Botanee Group has market cap of $2.5B and EV of $2.1B.
Botanee Group's trades at 2.4x LTM EV/Revenue multiple, and 16.9x LTM EBITDA.
Analysts estimate Botanee Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Botanee Group and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $2.1B | XXX | XXX | XXX |
EV/Revenue | 2.4x | XXX | XXX | XXX |
EV/EBITDA | 17.6x | XXX | XXX | XXX |
P/E | 25.4x | XXX | XXX | XXX |
P/E/Growth | 1.0x | XXX | XXX | XXX |
EV/FCF | 41.7x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpBotanee Group's NTM/LTM revenue growth is 13%
Botanee Group's revenue per employee for the last fiscal year averaged n/a, while opex per employee averaged n/a for the same period.
Over next 12 months, Botanee Group's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Botanee Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Botanee Group and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 16% | XXX | XXX | XXX | XXX |
EBITDA Margin | 14% | XXX | XXX | XXX | XXX |
EBITDA Growth | -13% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 27% | XXX | XXX | XXX | XXX |
Revenue per Employee | n/a | XXX | XXX | XXX | XXX |
Opex per Employee | n/a | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 40% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 3% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 5% | XXX | XXX | XXX | XXX |
Opex to Revenue | 59% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Acme United | XXX | XXX | XXX | XXX | XXX | XXX |
EZZ Life Science | XXX | XXX | XXX | XXX | XXX | XXX |
Live Verdure | XXX | XXX | XXX | XXX | XXX | XXX |
Lavipharm | XXX | XXX | XXX | XXX | XXX | XXX |
Sarantis Group | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Botanee Group acquired XXX companies to date.
Last acquisition by Botanee Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Botanee Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Botanee Group founded? | Botanee Group was founded in 2010. |
Where is Botanee Group headquartered? | Botanee Group is headquartered in China. |
Is Botanee Group publicy listed? | Yes, Botanee Group is a public company listed on SHE. |
What is the stock symbol of Botanee Group? | Botanee Group trades under 300957 ticker. |
When did Botanee Group go public? | Botanee Group went public in 2021. |
Who are competitors of Botanee Group? | Similar companies to Botanee Group include e.g. Acme United, EZZ Life Science, Live Verdure, Lavipharm. |
What is the current market cap of Botanee Group? | Botanee Group's current market cap is $2.5B |
What is the current revenue of Botanee Group? | Botanee Group's last 12-month revenue is $897M. |
What is the current EBITDA of Botanee Group? | Botanee Group's last 12-month EBITDA is $126M. |
What is the current EV/Revenue multiple of Botanee Group? | Current revenue multiple of Botanee Group is 2.4x. |
What is the current EV/EBITDA multiple of Botanee Group? | Current EBITDA multiple of Botanee Group is 16.9x. |
What is the current revenue growth of Botanee Group? | Botanee Group revenue growth between 2023 and 2024 was 16%. |
Is Botanee Group profitable? | Yes, Botanee Group is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.